Introduction
============

Silicone oil for use during vitreoretinal surgery was first reported in the United States by Paul Cibis in 1962, although almost two decades passed before the agent gained general acceptance among American vitreoretinal surgeons ([@b5-co-2-955]). The long-lasting retinal tamponade provided by silicone oil is of particular benefit when attempting to repair retinal detachments associated with severe proliferative vitreoretinopathy, diabetic retinopathy, viral retinitis, and ocular trauma (Gallemore and McCuen). Since its introduction, there has been controversy concerning the safety of silicone oil for intraocular use ([@b5-co-2-955]; [@b13-co-2-955]; [@b14-co-2-955]; [@b6-co-2-955]).

Removal of silicone oil is typically advocated for a number of reasons. Prolonged silicone oil tamponade has been demonstrated to induce anterior segment complications, including cataract, glaucoma, and keratopathy ([@b4-co-2-955]). Data obtained from enucleated, glaucomatous eyes suggest that silicone oil droplets can become impregnated within the neuroretina, pigment epithelium, optic nerve, and trabecular meshwork ([@b10-co-2-955]; [@b17-co-2-955]). Finally, removal of silicone oil is commonly associated with improved visual acuity because of the mitigation of refractive errors.

Unexplained loss of vision in eyes following silicone oil removal has recently been described in two reports ([@b11-co-2-955]; [@b3-co-2-955]). Although several possible hypotheses were advanced, neither report provides a conclusion as to the pathophysiology of the vision loss. The current study examines visual loss both during the time of silicone oil tamponade and after oil removal.

Methods
=======

Medical records were reviewed of all patients with a documented loss of visual acuity of at least three Snellen lines from best acuity with silicone oil in place or after removal of silicone oil at a single retina practice in Dallas and Arlington, Texas between 1996 and 2006. Data collected include age, gender, involved eye, type of retinal detachment, macular status at the time of surgery, type of surgery performed, duration (in days) of silicone oil fill, and visual acuity during and after silicone oil tamponade. Visual acuity through intraocular oil was recorded using a potential acuity meter. Visual acuity after oil removal was recorded with a Snellen chart. The results of any ancillary testing performed (such as fluoroscein angiography, optical coherence tomography \[OCT\], and perimetry) were also recorded.

Results
=======

Nine patients (six men, three women) with a mean age of 48 years (range, 16 to 61 years) met study inclusion criteria. Clinical characteristics of the study population are summarized in [Table 1](#t1-co-2-955){ref-type="table"}. In seven eyes, perfluorocarbon liquid was used during retinal detachment repair to flatten the retina. All cases were performed with 5000-centistoke silicone oil. All eyes underwent 360-degree laser retinopexy, and all eyes maintained retinal attachment.

Visual acuity data during and after the period of silicone oil tamponade are presented in [Table 2](#t2-co-2-955){ref-type="table"}. Seven patients lost at least three Snellen lines of vision while the silicone oil was in place. Four patients had late modest improvements in acuity when compared to their final recorded Snellen vision *before* silicone oil removal, however no patients exhibited visual improvement when comparing their final recorded visual acuities after oil removal with best recorded acuities under oil tamponade

The average time of silicone oil fill was 469 days (range, 80--3104 days; median 119 days). Patient 8 refused to have oil removal for eight years due to good vision with the oil in place. If the data from patient 8 is excluded as an outlier, a more representative mean of 139 days is derived. The median best recorded visual acuity by potential acuity meter testing with in place was 20/40 at a median of 27 days after oil placement (range, 6--1285 days; mean, 176 days; mean is 37 days if patient 8 is excluded). The median visual acuity by potential acuity meter at the last visit before removal of silicone oil was 20/200 (range, 20/40--20/400). Patients were followed for an average of 407 days (range, 65--1218 days) after silicone oil removal. The median best recorded visual acuity after oil removal was 20/120 (range, 20/40-count fingers) at a mean of 346 days post removal (range, 54--934 days). Patient 9 had a moderate vitreous hemorrhage on the first postoperative day that resolved spontaneously. The median final recorded visual acuity was 20/120 (range, 20/40-count fingers) at a median of 274 days (range, 65--1218 days; mean, 407 days).

The results of OCTs performed after silicone oil removal are described in [Table 4](#t4-co-2-955){ref-type="table"}. Patient 8 had a small macular hole diagnosed by OCT 72 days after oil removal. The macular hole resolved spontaneously 10 months later (confirmed by OCT), with improvement in visual acuity from 20/100 to 20/40. Fluorescein angiography was performed on patients 1, 2, and 3. The angiogram of patient 1 was notable for early punctate staining of the macula consistent with fine drusen, while patients 2 and 3 demonstrated normal angiography. Patient 2 had a normal Goldmann visual field after oil removal and potential acuity meter visual acuity testing ranging from 20/100 to 20/300 before cataract extraction.

At no time did any patients exhibit persistent spikes in intraocular pressures, and the investigators never had tangible reason to suspect that glaucoma played an important etiologic role in any of the aforementioned cases of inexplicable vision loss.

Discussion
==========

Vision loss associated with silicone oil use and removal is typically severe and permanent. Vision loss may be masked by the fact that many eyes that receive silicone oil tamponade have severe retinal conditions with poor central vision at the time of oil placement. Therefore, their physicians assume the subsequent limited central vision following oil removal is due to pre-existing retinal damage.

In the current study, seven of ten patients had a three Snellen line decrease in visual acuity recorded prior to silicone oil removal. [@b9-co-2-955] noted similar findings in a five-patient, retrospective study, documenting the development of subjective central scotomas in advance of oil removal. The oil was in place for an average of 2.7 months when the scotomas arose and were associated with decreased visual acuity and visual field defects.

Various theories have been offered to explain the vision loss associated with the use, or removal, of silicone oil tamponade (Table 5). According to the "vitreous potassium sink" theory, the vitreous cavity in a normal eye provides a reservoir for the release of potassium ions by Müller cells, thereby buffering intraretinal potassium spikes ([@b19-co-2-955]). This theory was first presented as an explanation for perfluorocarbon liquid toxicity. It is hypothesized that the aqueous volume between the perfluorocarbon and the retina is far too small to serve as a sufficient sink for the siphoning of potassium ions and that elevated retinal potassium concentration could trigger apoptosis and macular dysfunction. [@b3-co-2-955] proposed the same mechanism as an explanation for vision loss associated with silicone oil removal. [Figure 1](#f1-co-2-955){ref-type="fig"} demonstrates the existence of a oil-fluid interface over the foveal depression in a patient without unexpected vision loss. The rapid disruption in electrolyte concentration in the "potassium sink" may explain the sudden vision loss with silicone oil removal. Based on pattern electroretinogram and multifocal electrogram testing, [@b3-co-2-955] localized the damage to the outer retinal layers of the central macula.

The sporadically noted optic neuropathy following silicone oil removal has led to the hypothesis that a similar "sink" might exist within the optic cup ([@b16-co-2-955]). Based on OCT, an interface similar to that presented in [Figure 1](#f1-co-2-955){ref-type="fig"} exists over the optic cup. Another author, citing afferent pupillary defects in a handful of patients, points to posterior ischemic optic neuropathy as playing a possible causative role ([@b18-co-2-955]). This was deemed unlikely by Newsom and colleagues given their patients' relative youth, excellent vascular health, and, in 6 of 7 patients, preserved visual evoked potentials ([@b12-co-2-955]).

One group of investigators has documented increased concentrations of fibrogenic growth factors (notably basic fibroblast growth factor and interleukin-6) in the retro-oil fluid ([@b1-co-2-955]), although this would likely contribute more to perisilicone proliferation than unexplained vision loss following removal of silicone oil. No such perisilicone membranes were documented in these patients.

Silicone oil transmits certain frequencies of ultraviolet light more readily than the vitreous gel, and aphakic patients might be particularly susceptible to phototoxic damage ([@b2-co-2-955]). Moreover, silicone oil is believed to dissolve fat soluble elements from the retina, most notably lutein and zeaxanthin, both of which are widely thought to serve photo-protective roles ([@b15-co-2-955]; [@b8-co-2-955]).

The exact etiology of vision loss in the current study group is unknown. Confounding variables such as cataract surgery, high myopia, and macular detachment must be considered in some patients. Four of eight patients in this study had a decrease in the foveal depression on OCT (OCTs were not routinely performed, and were only utilized when the clinician could not ascertain another viable reason for poor visual function in the absence of obvious architectural abnormalities). The significance of this finding is unclear, but it could suggest a maculopathy with architectural foveal changes. Based on the "potassium sink" theory, the OCT changes could represent anatomic changes secondary to a localized foveal toxicity. Another possibility is simply poor fixation due to poor vision.

Conclusion
==========

The use of silicone oil is an important management tool for many complex retinal conditions. Future studies are warranted to evaluate the risk of unanticipated central visual loss.
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###### 

Patient and ocular characteristics in study population with visual acuity loss associated with silicone oil use or removal

  Patient nmber   Age   Reason for slicone oil            Associated pathology                  Macula detached preoperatively   Phakic prior to silicone oil   Cataract extraction?   Timing of cataract extraction and IOL
  --------------- ----- --------------------------------- ------------------------------------- -------------------------------- ------------------------------ ---------------------- ---------------------------------------------------
  1               61    Multiple inferior tears                                                 No                               Yes                            Yes                    After SO removal
  2               51    Giant retinal tear                                                      No                               Yes                            Yes                    After SO removal
  3               58    Inferior recurrent RD with PVR                                          No                               Yes                            Yes                    After SO removal
  4               16    Inferior RD with multiple tears   High myopia, Marfan's syndrome        No                               Yes                            Yes                    With SO removal
  5               37    Recurrent detachment with PVR     Optic neuritis, epiretinal membrane   No                               Yes                            No                     
  6               57    Recurrent inferior RD             High myopia                           No                               No                                                    
  7               52    Giant retinal tear                                                      No                               Yes                            Yes                    After SO removal
  8               44    Recurrent inferior RD with PVR    High myopia                           Yes                              No                                                    
  9               57    Giant retinal tear                                                      Yes                              Yes                            Yes                    Extraction with SO placement, IOL with SO removal

**Abbreviations:** IOL, Intraocular lens; PVR, proliferative vitreoretinopathy; RD, retinal detachment; SO, silicone oil.

###### 

Visual acuity (VA) characteristics during and after silicone oil tamponade

  Pt \#   Best VA with oil (PAM)   Days b/t oil placement and best VA   VA at final exam before oil removal (PAM)   Total days with oil   Best VA after oil removal   Days between oil removal and final recordedVA   Final recordedVA
  ------- ------------------------ ------------------------------------ ------------------------------------------- --------------------- --------------------------- ----------------------------------------------- ------------------
  1       20/40                    27                                   20/200                                      119                   CF                          249                                             CF
  2       20/50                    20                                   20/70                                       80                    20/60                       386                                             20/60
  3       20/40                    69                                   20/200                                      147                   20/200                      496                                             20/400
  4       20/50                    20                                   20/200                                      248                   20/100                      65                                              20/100
  5       20/40                    8                                    20/300                                      96                    20/120                      113                                             20/120
  6       20/60                    59                                   20/400                                      224                   20/400                      1218                                            CF
  7       20/40                    89                                   20/40                                       111                   20/100                      274                                             20/100
  8       20/30                    1285                                 20/70                                       3104                  20/40                       758                                             20/40
  9       20/25                    6                                    20/100                                      88                    20/400                      105                                             20/400

###### 

Optical coherence tomography findings after silicone oil removal

  Patient number   Time after oil removal (Days)   Foveal thickness (microns)   Comments
  ---------------- ------------------------------- ---------------------------- --------------------------------
  1                11                              204                          Decreased foveal depression
  2                24                              187                          Normal OCT
  3                48                              243                          No foveal depression, mild CME
  4                65                              189                          Decreased foveal depression
  5                41                              248                          Decreased foveal depression
  6                1218                            140                          Thin, myopic fundus
  7                36                              209                          Decreased foveal depression
  8                72                              n/a                          Small macular hole
  9                --                              --                           No OCT performed

**Abbreviations:** CME, cystoid macular edema; OCT, optical coherence tomography.

###### 

Potential mechanisms of vision loss associated with the use, or removal, of silicone oil

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Vitreous potassium sinkFibrogenic growth factorsOcular factors (macula-off detachment, myopia, cataract, posterior ischemic optic neuropathy)Ultraviolet lightReduced fat soluble factors (eg, lutein and zeaxanthin)
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
